Jarmo Oksi - Infectious Diseases

Author Information

Jarmo Oksi is a distinguished researcher associated with the Department of Infectious Diseases at Turku University Hospital and Turku University, located in Turku, Finland. His work predominantly focuses on infectious diseases, contributing significantly to the field through both research and clinical practice.

Research Contributions

Jarmo Oksi has made substantial contributions to the field of infectious diseases, with particular emphasis on topics related to COVID-19, Lyme disease, and bacterial infections. His work includes studies on SARS-CoV-2 seroprevalence among healthcare workers, the use of tocilizumab in COVID-19 treatment, and comparisons of antibiotic treatments in Lyme neuroborreliosis. He has also explored the association between sleep apnea and COVID-19, as well as the rapid detection of bacterial infections using novel methods. His research spans both clinical trials and observational studies, aiming to enhance the understanding and management of infectious diseases.

Aliases

Jarmo Oksi is also known by variations of his name, including J Oksi and J. Oksi. These aliases are commonly used in academic publications and citations.

Publication and Citation Metrics

Metric	Value
Total Papers	92
Total Citations	2730
h-index	26

Publications:

Low pre-vaccination SARS-CoV-2 seroprevalence in Finnish health care workers: a prospective cohort study

DOI: 10.1080/23744235.2022.2027008

Year: 2022

Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study

DOI: 10.1016/j.cmi.2022.02.027

Year: 2022

Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients

DOI: 10.3389/fimmu.2022.869990

Year: 2022

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.

DOI: 10.1001/jama.2021.11330

Year: 2021

Consumption of healthcare services and antibiotics in patients with presumed disseminated Lyme borreliosis before and after evaluation of an infectious disease specialist.

DOI: 10.1016/j.ttbdis.2021.101854

Year: 2021

Rapid detection of bacterial infection using a novel single-tube, four-colour flow cytometric method: Comparison with PCT and CRP

DOI: 10.1016/j.ebiom.2021.103724

Year: 2021

Short- and long-term outcomes of infective endocarditis admission in adults: A population-based registry study in Finland

DOI: 10.1371/journal.pone.0254553

Year: 2021

Clinical characteristics and evaluation of the incidence of cryptococcosis in Finland 2004–2018

DOI: 10.1080/23744235.2021.1922753

Year: 2021

Oral doxycycline compared to intravenous ceftriaxone in the treatment of Lyme neuroborreliosis: a multicentre, equivalence, randomized, open-label trial.

DOI: 10.1093/cid/ciaa217

Year: 2020

Is sleep apnoea a risk factor for Covid-19? Findings from a retrospective cohort study

DOI: 10.1101/2020.05.14.20098319

Year: 2020

What Preventive Measures are Available?

How is Malaria Diagnosed?

What is Genetic Immunity?

Can the Immune System Overreact?

What is the public health impact of Neisseria gonorrhoeae?

What Are the Side Effects of Antimalarial Drugs?

What is the Role of Genomics in Tracking Disease Outbreaks?

How are Zoonoses Transmitted?

Why are Chest CT Scans Important in Infectious Diseases?

What is Disease Eradication?

Partnered Content Networks

Relevant Topics